賽托瑞醫療 CYTX 深 滬
等待開盤 03-26 09:30:00 美东时间
0.2077
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 0.2077
- 總市值 376.46万
- 52周最高 562.50
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 153.00
- 委 比 0.00%
- 總股本 1812.50万
- 歷史最高 554625.00
- 量 比 0
- 振 幅 0.00%
- 歷史最低 153.00
- 每 手 1
- 風險率 0.00%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Plus Therapeutics to present CNSide analysis showing 40% leptomeningeal metastases cost reduction at ISPOR 2026
Plus Therapeutics to present CNSide analysis showing 40% leptomeningeal metastases cost reduction at ISPOR 2026 Plus Therapeutics is scheduled to present a health economics poster at the ISPOR 2026 Annual Meeting on May 17-20, 2026, in Philadelphia, Pennsylvania. The poster reports a cost-of-care an
03-19 19:31
Plus Therapeutics to Present New Analysis at ISPOR Showing CNSide® May Reduce Leptomeningeal Metastases Healthcare Costs by 40%
Plus Therapeutics announced a health economics study showing that earlier detection of leptomeningeal metastases (LM) using CNSide® CSF Assay may reduce LM-related healthcare costs by about 40% through improved treatment precision and reduced hospitalizations. The findings will be presented at the ISPOR 2026 Annual Meeting. CNSide provides early actionable information, and the analysis highlights substantial cost savings and improved patient outc...
03-19 11:30
Plus Therapeutics Announces New Category III CPT Code for REYOBIQ Convection-Enhanced Delivery
Plus Therapeutics Announces New Category III CPT Code for REYOBIQ Convection-Enhanced Delivery Plus Therapeutics Inc. said the American Medical Association’s CPT Editorial Panel approved a new Category III CPT code to track utilization of convection-enhanced delivery used to administer REYOBIQ for r
02-25 20:30
U.S. RESEARCH ROUNDUP-Applied Materials, Procter & Gamble, RLI
U.S. RESEARCH ROUNDUP-Applied Materials, Procter & Gamble, RLI Jan 23 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Applied Materials, Procter & Gamble and RLI, on Friday. HIGHLIGHTS * Applied Materials Inc AMAT.O : Be
01-23 15:13
Plus Therapeutics to Provide Business Update and Host Conference Call on Thursday, January 22, 2026 at 9:00 A.M. ET
Houston-based Plus Therapeutics, Inc. announces it will provide a business update on January 22, 2026, followed by a conference call and webcast at 9:00 AM ET. To join, dial 1-888-349-0106 or visit the provided webcast link. A replay will be available on the company’s website. Plus Therapeutics specializes in developing precision diagnostics and radiopharmaceuticals for CNS cancers.
01-21 21:15
CNSide Diagnostics Expands CNSide Assay Platform to California
Plus Therapeutics' Subsidiary CNSide Diagnostics Expands CNSide Assay Platform to California Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intellige...
2025-12-11 20:30
Plus Therapeutics Grants Stock Options and RSUs to New CNSide Diagnostics Hires
Plus Therapeutics Inc. has granted stock options and restricted stock units (RSUs) to two new hires, Mr. Gurnani and Ms. Luckey, at its CNSide Diagnostics subsidiary. Each employee received options to...
2025-12-09 20:30
BRIEF-Plus Therapeutics Secures National Coverage Agreement With Humana For Cnside® Cerebrospinal Fluid Assay For Metastatic Cns Cancer
Humana Inc HUM.N: PLUS THERAPEUTICS SECURES NATIONAL COVERAGE AGREEMENT WITH HUMANA FOR CNSIDE® CEREBROSPINAL FLUID ASSAY FOR METASTATIC CNS CANCER Source text: ID:nGNX4wwSmR Further company coverage:...
2025-11-20 21:14
Plus Therapeutics CFO Andrew Sims Reports Acquisition of Common Shares
Andrew John Hugh MacIntyre Sims, Chief Financial Officer of Plus Therapeutics Inc., has reported the acquisition of common shares of the company. The full filing can be accessed through the link below...
2025-11-05 21:30
U.S. RESEARCH ROUNDUP- Crowdstrike, Guardant Health, Palantir Technologies
Nov 3 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Crowdstrike, Guardant Health and Palantir Technologies on Monday. ...
2025-11-03 15:35
